应用环孢素A建立eb病毒转化的人淋巴母细胞样细胞系。

In Vitro Pub Date : 1984-11-01 DOI:10.1007/BF02619631
M A Anderson, J F Gusella
{"title":"应用环孢素A建立eb病毒转化的人淋巴母细胞样细胞系。","authors":"M A Anderson,&nbsp;J F Gusella","doi":"10.1007/BF02619631","DOIUrl":null,"url":null,"abstract":"<p><p>We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.</p>","PeriodicalId":13317,"journal":{"name":"In Vitro","volume":"20 11","pages":"856-8"},"PeriodicalIF":0.0000,"publicationDate":"1984-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02619631","citationCount":"91","resultStr":"{\"title\":\"Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.\",\"authors\":\"M A Anderson,&nbsp;J F Gusella\",\"doi\":\"10.1007/BF02619631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.</p>\",\"PeriodicalId\":13317,\"journal\":{\"name\":\"In Vitro\",\"volume\":\"20 11\",\"pages\":\"856-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1984-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/BF02619631\",\"citationCount\":\"91\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In Vitro\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF02619631\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In Vitro","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02619631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 91

摘要

我们已经研究了使用环孢素A来提高制备eb病毒转化人淋巴母细胞系的效率的潜力。这种免疫抑制药物的使用使得一种成功率超过95%的治疗方法得以发展,尽管需要处理大量的样本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

We have investigated the potential for using cyclosporin A to increase the efficiency with which Epstein-Barr virus-transformed human lymphoblast lines can be prepared. Use of this immunosuppressive drug has permitted the development of a procedure with success rates exceeding 95% despite the processing of very large numbers of samples.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信